MedTrace Logo

Neuromuscular Ultrasound in ALS

NCT01785550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-03-11

No results posted yet for this study

Summary

Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease affecting motor neurons. Early diagnosis is essential for the success of clinical trials and objective biomarkers are needed for monitoring disease progression. Nerve and muscle ultrasound may provide this information.

This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to identify and monitor disease progression in ALS.

Conditions

Interventions

OTHER

Ultrasound of nerve and muscle

Ultrasound of 6 muscles and 2 nerves will be performed.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785550 on ClinicalTrials.gov